PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Share News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks recover some of recent Fed talk losses

Thu, 18th Apr 2024 16:52

(Alliance News) - Stock prices in London closed up on Thursday, despite the prospect of higher for longer US interest rates hanging over stocks, while initial jobless claims for the week came in steady.

The FTSE 100 index closed up 29.06 points, 0.4%, at 7,877.05. The FTSE 250 ended up 110.53 points, 0.6%, at 19,450.67, and the AIM All-Share closed up 2.17 points, up 0.3%, at 745.29.

The Cboe UK 100 ended up 0.2% at 786.93, the Cboe UK 250 closed up 0.3% at 16,833.88, and the Cboe Small Companies ended marginally up at 14,776.22.

US jobless claims were steady in the most recent week, according to the US Department of Labor.

In the week ending April 13, US initial jobless claims were unchanged from the previous week's revised level at 212,000. The previous week's level was revised up by 1,000 from 211,000.

This was lower than market consensus for initial jobless claims to rise to 215,000.

The four-week moving average was 214,500, unchanged from the previous week's revised average. The previous week's average was revised up by 250 from 214,250.

Stocks in New York were higher at the London equities close, with the DJIA up 0.8%, while the S&P 500 index and the Nasdaq Composite were both up 0.5%.

In European equities on Thursday, the CAC 40 in Paris and the DAX 40 in Frankfurt both ended up 0.5%.

Global equities began to recover, with most major indices down on-week.

"Fears that interest rates will stay higher for longer, as inflation stubbornly does the same, mean the yield on government bonds are also refusing to go down and that in turn is starting to put a little pressure on share prices," said AJ Bell analyst Russ Mould.

"This is partly because investors can grab a higher yield on certain UK gilts or US Treasuries than they can from headline share indices and do so for less risk, at least in theory."

Against the dollar, sterling rose to USD1.2464 at the London equities close on Thursday, from USD1.2447 late Wednesday. The euro was up at USD1.0660, from USD1.0637. Against the yen, the buck bought JPY154.60, down from JPY154.67.

In London's FTSE 100, British Airways parent International Consolidated Airlines Group rose 4.3% in a positive read-across from budget airline easyJet.

easyJet rose 2.3%, after it reported a "positive outlook" for the remainder of its financial year, and said its "seasonal" losses eased in the first half. Sales amounted to EUR819.6 million in the quarter, down 9.3% from EUR903.2 million a year prior.

In the six months to March 31, revenue surged 22% to GBP3.27 billion from GBP2.69 billion. Its headline pretax loss slimmed to GBP350 million from GBP411 million.

"Easter demand was particularly strong, benefitting March due to its early timing. Operational performance was good with peak daily flights broadly in line with summer levels," it said. "Bookings for summer 2024 continue to build well, with an increase in volume and pricing compared to the same period last year, underpinned by strong demand for easyJet's primary airport network."

Segro rose 1.6%, after the property investment firm hailed "strong growth" in rent roll during the first quarter of the year as it noted a stabilisation of industrial and logistics asset values.

It reported total new headline rent signed of GBP29 million during the first quarter of 2024, up 21% from GBP24 million a year prior.

The occupancy rate edged down to 94.5% from 95.7% year-on-year due to speculative development completions. Customer retention edged up to 90% from 82%.

In London's FTSE 250, Hipgnosis Songs Fund jumped 30%. It has agreed to a USD1.40 billion cash takeover from music rights acquirer Alchemy Copyrights, which trades as Concord.

Concord will pay USD1.16, or 93.2 pence, in cash per Hipgnosis Songs Fund share. The price is a 32% premium to its Wednesday close.

Concord said Higpnosis Songs Fund shareholders will stand to receive up to an extra USD25 million in total, if the investment adviser deal with Hipgnosis Song Management is ended.

Hipgnosis Songs Fund is in dispute with its investment adviser, alleging misconduct against Hipgnosis Songs Management and its founder Merck Mercuriadis.

The dispute was sparked by an arrangement, later rejected by Hipgnosis Songs Fund shareholders, to sell part of the fund's portfolio to a joint venture between Hipgnosis Songs Management and private equity firm Blackstone. This triggered board changes at the fund.

Among London's small-caps, Petrofac rose 2.7%, after it was awarded a technical services contract with the national oil company of Equatorial Guinea, helping local staff to manage their oil and gas assets.

The energy infrastructure company with core markets in the Middle East and North Africa won a five-year USD350 million contract with Compania Nacional de Petroleos de Guinea Ecuatorial, or GEPetrol, to deliver technical services to the operation of Equatorial Guinea's regional Block B asset.

The contract draws on Petrofac services such as operations, maintenance, asset integrity, integrity management, marine services, well engineering, project delivery and supply chain services.

Petrofac will deliver technical services across onshore support bases, a floating production storage & offloading unit and a platform on behalf of operator GEPetrol.

On AIM in London, Surgical Innovations rose 25%, after the surgical and medical instrument manufacturer reported that revenues increased to GBP12.01 million from GBP11.3 million a year earlier, slightly exceeding board expectations.

Pretax loss widened to GBP728,000 from GBP57,000.

Surgical Innovations also agreed two new UK distribution contracts. The first is a five-year exclusive contract with Microline Surgical Inc, Boston, US, and the second is a three-year exclusive arrangement with Peters Surgical, based in Paris, France.

A barrel of Brent oil slumped to USD87.15 at the London equities close on Thursday from USD88.68 late Wednesday.

Gold traded at USD2,384.41 an ounce at the London equities close on Thursday, up slightly from USD2,383.47 on Wednesday.

In Friday's UK corporate calendar, Man Group posts a trading statement.

The economic calendar has German producer price inflation and UK retail sales data both out at 0700 SAT.

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
15 Apr 2014 08:38

Surgical Innovations Profit Hit By Investment, Exchange Rate

LONDON (Alliance News) - Surgical Innovations Group PLC Tuesday posted a decline in pretax profit for 2013, despite seeing revenue rise, due to the US Dollar exchange rate and its investment in streamlining its manufacturing operations. Surgical Innovations produces devices for use in minim

Read more
15 Apr 2014 07:50

UK MORNING BRIEFING: Aggreko Leads After Mixed Results

LONDON (Alliance News) - Aggreko is leading the FTSE 100 in early trading Tuesday after the temporary power company said it has seen mixed results in its first quarter, with strong underlying revenue growth in two of its three regions being impacted by adverse currency movements as previously exp

Read more
6 Feb 2014 14:02

Sector movers: Mobile telecoms, healthcare stocks rise as results impress

The mobile telecoms and healthcare categories were putting in decent performances on Thursday in London after results from sector heavyweights Vodafone and Smith & Nephew impressed. Vodafone gained 2.4% in afternoon trade after revenues declined by a less-than-expected 3.6% in the third quarter to

Read more
17 Jan 2014 11:31

Surgical Innovations profits hit by invest plan and exchange rates

Shares in Surgical Innovations declined sharply after the company warned its profits had been hit by the US dollar exchange rate and its investment during the second half. The company, which develops solutions for minimally invasive surgery, said it therefore expected 2013 earnings before interest

Read more
17 Jan 2014 10:15

UK BROKER RATING CHANGES: Goldman Raises View On Insurance Sector

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
SOCGEN STARTS MORRISON WITH 'SELL' - TARGET 200 PENCE
----------
SOCGEN CUTS PRICE TARGET TESCO TO 270 (290) PENCE -

Read more
17 Jan 2014 10:05

Friday broker round-up UPDATE

Aberdeen Asset Management: JP Morgan cuts target price from 544p to 529p, while its overweight rating remains unchanged. Canaccord Genuity reduces target price from 586p to 540p and reiterates a buy recommendation. UBS lowers target price from 540p to 520p and keeps a buy recommendation. Ashtead Gr

Read more
17 Jan 2014 08:28

Surgical Innovations Shares Drop On Profit Warning

LONDON (Alliance News) - Shares in Surgical Innovations Group PLC fell sharply Friday morning after it said that its adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) for the full year ended December 31 would be significantly below the previous year. The company

Read more
17 Jan 2014 08:13

UK MORNING BRIEFING: Shares Open Higher Despite Shell Warning

LONDON (Alliance News) - UK shares have opened higher Friday despite negative news from two FTSE 100 companies, Royal Dutch Shell and Shire.

The oil major issued a profit warning, and the pharmaceutical firm said it will book a loss on the sale of

Read more
5 Nov 2013 10:28

Surgical Innovations Ships First Products Under Surgioscopy Deal

Read more
24 Oct 2013 10:29

Surgical Innovations To Develop New Production Facility In Leeds

Read more
4 Oct 2013 10:28

Surgical Innovations Appoints Romain Pizzi To Clinical Advisory Board

Read more
10 Sep 2013 10:23

Surgical Innovations Group Profits Jump As Sales Increase 28%

Read more
10 Sep 2013 09:15

Surgical Innovations adds progress in US to strong UK H1

Keyhole surgery equipment specialist Surgical Innovations sold more of its own branded products in the first half, leading to a strong rise in profits. The AIM-listed company, which flagged up these results in a pre-close statement, revealed its efforts to push into the US had resulted in an expan

Read more
10 Sep 2013 08:17

Tuesday broker round-up UPDATE

African Barrick Gold: Investec shifts target price from 135p to 137p, while downgrading from hold to sell. Aquarius Platinum: JP Morgan moves target price from 39p to 49p, while downgrading from neutral to underweight. Citi lowers target price from 66p to 54p and downgrades from buy to neutral. As

Read more
16 Aug 2013 08:44

Surgical Innovations triples profits in first half

First half profits have more than tripled at keyhole surgery equipment maker Surgical Innovations as many UK hospitals convert to using its products. The AIM company said revenues for the six months to end-June were 28% ahead of the same period last year at £3.88m, with profit before tax for the p

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.